deltatrials

Multiple myeloma Trials in Kayseri, Turkey (türkiye)

Conditions / Multiple myeloma / Kayseri, Turkey (türkiye)

Clinical trials for Multiple myeloma investigate a range of treatment strategies and patient populations.

16 total trials for this combination

Showing top 10 of 16 trials

Trials

NCT ID Title Status Phase
NCT02761187 An Observational Study of Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma Participants TERMINATED
NCT02136134 Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma COMPLETED PHASE3
NCT04975997 Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM) ACTIVE_NOT_RECRUITING PHASE3
NCT02195479 A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma COMPLETED PHASE3
NCT05020236 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments RECRUITING PHASE3
NCT01241396 A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure COMPLETED
NCT05317416 Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant ACTIVE_NOT_RECRUITING
NCT02181413 A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell Transplant COMPLETED PHASE3
NCT05243797 Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation RECRUITING PHASE3
NCT05827016 A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma RECRUITING PHASE3

Related Pages